For a Pleasant Hills couple, it's also the day one year ago, when they started a life-saving journey at Allegheny General ...
Race may play a role in the waitlist experience, allograft quality and transplant outcomes of patients with autosomal ...
Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, published in Science, from researchers at the Perelman School of Medicine at the ...
A new study in mice suggests that long-term exposure to low levels of traffic-related air pollution can damage the liver and ...
Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective NaV1.8 ...
KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.
A personalized approach to protein intake for patients with polycystic kidney disease should be based on disease stage, health status, and lifestyle. Protein needs in polycystic kidney disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback